-
Mashup Score: 2
This review provides a summary of presentations from the virtual American College of Rheumatology (ACR) Convergence 2020 meeting…
Source: European Medical JournalCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
This review provides a summary of presentations from the virtual American College of Rheumatology (ACR) Convergence 2020 meeting…
Source: European Medical JournalCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
This review provides a summary of presentations from the virtual American College of Rheumatology (ACR) Convergence 2020 meeting…
Source: European Medical JournalCategories: Latest Headlines, RheumatologyTweet-
This review provides a summary of presentations from the ACR Convergence 2020 meeting and collectively describes #psoriasis, psoriatic #arthritis (PsA), and spondyloarthritis (SpA), with a focus on the role of immune function to aid clinicians. https://t.co/QiYQKXAI3H #ACR2020 https://t.co/M8JFaWK7nK
-
-
Mashup Score: 0'Lipid Paradox' Seen in Nonobese RA Patients With Low LDL - 3 year(s) ago
A complex dynamic exists between traditional risk factors and cardiovascular events in RA patients, said an investigator.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4'Lipid Paradox' Seen in Nonobese RA Patients With Low LDL - 3 year(s) ago
A complex dynamic exists between traditional risk factors and cardiovascular events in RA patients, said an investigator.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0'Lipid Paradox' Seen in Nonobese RA Patients With Low LDL - 3 year(s) ago
A complex dynamic exists between traditional risk factors and cardiovascular events in RA patients, said an investigator.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Denosumab Was the Most Frequently Initiated Osteoporosis Drug in 2018, ACR Study Finds - 3 year(s) ago
The results of a study presented at ACR 2020 demonstrate that a greater proportion of patients were initiated on denosumab compared with bisphosphonates for the first time—18.5% compared with 16.9%— in 2018.
Source: Rheumatology NetworkCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Puja Khanna MD, MPH, associate professor of medicine at the University of Michigan, discusses a presentation she gave at the American College of Rheumatology Convergence 2020 on reducing the immunogenicity of pegloticase and improving its efficacy.
Source: Rheumatology NetworkCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
-
Don’t miss what’s happeningPeople on Twitter are the first to know.
Read the original tweet here
Source: TwitterCategories: Healthcare Professionals, Latest HeadlinesTweet -
-
Mashup Score: 0MDedge Log In - 4 year(s) ago
About Privacy Policy Terms of Use Cookies Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.
Source: login.medscape.comCategories: Latest Headlines, PediatricsTweet
This review provides a summary of presentations from the ACR Convergence 2020 meeting and collectively describes #psoriasis, psoriatic #arthritis (PsA), and spondyloarthritis (SpA), with a focus on the role of immune function to aid clinicians. https://t.co/QiYQKXAI3H #ACR2020 https://t.co/mjG7THV3Is